Ultima Business Solutions

Application Infrastructure

TNS | December 13, 2021

With 5G roaming and interworking on the horizon, US-based Transaction Network Services (TNS) will collaborate with Irish solutions provider, Cellusys, in research, development, and testing of roaming and security solutions for 5G networks. Utilizing the TNS 5G Innovation Lab, the team will combine TNS’ expertise in steering of roaming and other services for regional and national US carriers for 3G, 4G, and soon 5G traffic with security solutions from the Cellusys portfolio, ...

IT Systems Management

C3 Complete | June 21, 2022

C3 Complete, an award-winning technology service provider, and iM Critical, a data center and IT services company shaping the future of IT infrastructure, are pleased to announce the formation of a strategic partnership. Customers of iM Critical’s data centers will immediately gain access to C3’s extensive suite of technology services, and customers of C3 will benefit from the ultra-modern capabilities of iM Critical’s facilities. The combined services of these two companies wi...

prnewswire | September 28, 2020

Iver is acquiring the Swedish cloud provider City Network. The acquisition creates a new European cloud alternative for Swedish and international enterprises, with a need for a comprehensive, secure, and technical global base for their digital innovation. The complex regulatory situation connected to use of different IT services in Europe, means that familiarity with the local market, its legal and commercial conditions - is an important common base for the joint offer."Combining digital in...

Application Infrastructure

Simulations Plus | January 16, 2023

Simulations Plus, Inc. recently announced that its DILIsym Services (DSS) division released DILIsym® version X (DSX) Beta, the latest iteration of its flagship quantitative systems toxicology (QST) software for predicting and investigating drug-induced liver injury (DILI). DILIsym modeling aids vital drug development decisions by prevising the potential DILI risk of new drug candidates. The modeling also identifies the biochemical events that contribute to DILI caused by a med...